Eli Lilly & Co. (LLY) Misses Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $724.87 -1%
EPS Growth %: +51.9%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +51.9%
Financial Fact:
Research and development: 1.24B
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.88, $0.07 worse than the analyst estimate of $0.95. Revenue for the quarter came in at $5.19 billion versus the consensus estimate of $5.29 billion.
Cialis revenue was $588.2 million. Est. at $594.7 million
Alinta revenue was $570.4 million, est at $551.7 million.
Eli Lilly & Co. reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
